end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrentAndNoncurrent,AccountsPayableRelatedPartiesCurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AllocatedShareBasedCompensationExpense,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,Cash,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CommonStockCapitalSharesReservedForFutureIssuance,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,ConversionOfStockSharesIssued1,DeferredCosts,DeferredOfferingCosts,Depreciation,EarningsPerShareBasicAndDiluted,EmployeeRelatedLiabilitiesCurrent,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized,FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue,GeneralAndAdministrativeExpense,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities,IncreaseDecreaseInOtherNoncurrentAssets,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InterestIncomeExpenseNonoperatingNet,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,MoneyMarketFundsAtCarryingValue,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NetIncomeLossAvailableToCommonStockholdersBasic,OperatingExpenses,OperatingIncomeLoss,OtherAssetsNoncurrent,OtherLiabilitiesCurrent,OtherNonoperatingExpense,OtherNonoperatingIncomeExpense,PaymentsOfStockIssuanceCosts,PaymentsToAcquirePropertyPlantAndEquipment,PrepaidExpenseAndOtherAssetsCurrent,ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,ResearchAndDevelopmentExpense,RetainedEarningsAccumulatedDeficit,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum,ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,StockholdersEquity,StockholdersEquityNoteStockSplitConversionRatio1,StockIssuedDuringPeriodSharesStockOptionsExercised,TemporaryEquityAccretionToRedemptionValueAdjustment,TemporaryEquityParOrStatedValuePerShare,TemporaryEquitySharesAuthorized,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,AccountsPayableCurrent,CapitalExpendituresIncurredButNotYetPaid,CommonStockValue,DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance,InterestExpense,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,Liabilities,OperatingLeaseExpense,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeaseRightOfUseAsset,OperatingLeaseWeightedAverageDiscountRatePercent,ProceedsFromIssuanceOfCommonStock,ProceedsFromRelatedPartyDebt,ProceedsFromStockOptionsExercised,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueStockOptionsExercised
2021-06-30,2021-08-16,10-Q,"AEROVATE THERAPEUTICS, INC.",AVTE,CIK0001798749,USD,3042000.0,9000.0,5000.0,407000.0,321000.0,321000.0,,62434000.0,59309000.0,1400000.0,59150000.0,59150000.0,,18721808.0,0.0001,50000000.0,243076.0,243076.0,,3000000.0,297000.0,,-23.8,258000.0,9400000.0,0.0,1447000.0,,,,,2000.0,62434000.0,4193000.0,57800000.0,,,,-5775000.0,-5784000.0,5774000.0,-5774000.0,3090000.0,120000.0,3000.0,-1000.0,,,159000.0,,40000.0,35000.0,4327000.0,-21985000.0,,0.0,0.696,0.687,,0.012,0.01,1768000.0,,,,47439000.0,2770954.0,5.69,829000.0,41250.0,2.72,47439000.0,2770954.0,5.69,,,-21578000.0,,,-9000.0,,,243076.0,,,,,,,,,,,,,,,,,,,,,,,,
2021-09-30,2021-11-15,10-Q,"AEROVATE THERAPEUTICS, INC.",AVTE,CIK0001798749,USD,,9000.0,,208015000.0,845000.0,845000.0,,184125000.0,183102000.0,1600000.0,180878000.0,180878000.0,,4768954.0,0.0001,150000000.0,24410393.0,24410393.0,,0.0,,,-0.26,365000.0,8800000.0,0.0,2782000.0,,,,,16000.0,184125000.0,3825000.0,179300000.0,,,,-6184000.0,-6184000.0,6200000.0,-6200000.0,278000.0,180000.0,,16000.0,,,2224000.0,,,162000.0,3418000.0,-28169000.0,,,0.695,0.694,,0.011,0.009,1738380.0,,,,42442000.0,2800574.0,5.79,2873000.0,172729.0,4.35,42442000.0,2800574.0,5.79,,,179848000.0,,,,,,23885017.0,2555000.0,,2000.0,230000.0,,661000.0,216000.0,206000.0,221000.0,18000.0,62000.0,4277000.0,16000.0,599000.0,147000.0,452000.0,583000.0,0.06,,,,,126946000.0,
